Search research articles
Contact Us
Filters
Showing results (741-750 of 1,427) with videos related to
Page
of 143
Sort By:
Scientific Reports
|
February 25, 2016
Camphor-mediated synthesis of carbon nanoparticles, graphitic shell encapsulated carbon nanocubes and carbon dots for bioimaging
Goldie Oza, M Ravichandran, Victor-Ishrayelu Merupo, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
November 19, 2016
Prevention of carboplatin-induced hypersensitivity reactions in women with ovarian cancer
Katarzyna J Jerzak, Shaidah Deghan Manshadi, Pamela Ng, et al.
Nature Reviews. Disease Primers
|
December 12, 2024
Ectopic pregnancy
Krystle Y Chong, Liesl de Waard, Munira Oza, et al.
Journal of Nanoscience and Nanotechnology
|
January 5, 2016
Synthesis of Culn(1-x)Ga(x)Se2 Nanoparticles by Thermal Decomposition Method with Tunable Ga Content
M Latha, R Aruna Devi, S Velumani, et al.
British Journal of Cancer
|
January 1, 1993
2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies
T Hickish, P Serafinowski, D Cunningham, et al.
The Laryngoscope
|
December 14, 2022
Exome Sequencing Expands the Genetic Diagnostic Spectrum for Pediatric Hearing Loss
Julia Perry, Shelby Redfield, Andrea Oza, et al.
Breast Cancer Research : BCR
|
December 28, 2022
Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness
Natalie S Joe, Inês Godet, Nubaira Milki, et al.
Annals of the Rheumatic Diseases
|
July 13, 2017
Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study
Amar Oza, Na Lu, Sara R Schoenfeld, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2005
Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors
M Moore, H W Hirte, L Siu, et al.
Lancet (London, England)
|
October 5, 2014
Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis
Li Liu, Shefali Oza, Daniel Hogan, et al.
Page
of 143
Search research articles
Search
Showing results (741-750 of 1,427) with videos related to
Sort By:
Page
of 143
Scientific Reports
|
February 25, 2016
Camphor-mediated synthesis of carbon nanoparticles, graphitic shell encapsulated carbon nanocubes and carbon dots for bioimaging
Goldie Oza, M Ravichandran, Victor-Ishrayelu Merupo, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
November 19, 2016
Prevention of carboplatin-induced hypersensitivity reactions in women with ovarian cancer
Katarzyna J Jerzak, Shaidah Deghan Manshadi, Pamela Ng, et al.
Nature Reviews. Disease Primers
|
December 12, 2024
Ectopic pregnancy
Krystle Y Chong, Liesl de Waard, Munira Oza, et al.
Journal of Nanoscience and Nanotechnology
|
January 5, 2016
Synthesis of Culn(1-x)Ga(x)Se2 Nanoparticles by Thermal Decomposition Method with Tunable Ga Content
M Latha, R Aruna Devi, S Velumani, et al.
British Journal of Cancer
|
January 1, 1993
2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies
T Hickish, P Serafinowski, D Cunningham, et al.
The Laryngoscope
|
December 14, 2022
Exome Sequencing Expands the Genetic Diagnostic Spectrum for Pediatric Hearing Loss
Julia Perry, Shelby Redfield, Andrea Oza, et al.
Breast Cancer Research : BCR
|
December 28, 2022
Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness
Natalie S Joe, Inês Godet, Nubaira Milki, et al.
Annals of the Rheumatic Diseases
|
July 13, 2017
Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study
Amar Oza, Na Lu, Sara R Schoenfeld, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2005
Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors
M Moore, H W Hirte, L Siu, et al.
Lancet (London, England)
|
October 5, 2014
Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis
Li Liu, Shefali Oza, Daniel Hogan, et al.
Page
of 143